Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
NCT00532532
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Muscle Spasticity
Interventions
DRUG:
tolperisone HCl
DRUG:
tolperisone HCl
DRUG:
tolperisone HCl
Sponsor
Avigen